Advertisement
Heart, Lung and Circulation

Peripheral Arterial Disease in Patients With Acute Coronary Syndrome: Results From a Large Real-World Registry

      Background

      Limited data exist regarding the significance of peripheral arterial disease (PAD) in patients with acute coronary syndrome (ACS).

      Methods

      We evaluated 16,922 consecutive ACS patients who were prospectively included in a national ACS registry. The co-primary endpoint included 30 days major adverse cardiovascular event (MACE) (re-infarction, stroke, and/or cardiovascular death) and 1-year mortality.

      Results

      PAD patients were older (70±11 vs 63±13; p<0.01), male predominance (80% vs 77%; p=0.01), and more likely to sustain prior cardiovascular events. PAD patients were less likely to undergo coronary angiography (69% vs 83%; p<0.001) and revascularisation (80% vs 86%; p<0.001). Patients with PAD were more likely to sustain 30-day MACE (22% vs 14%; p<0.001) and mortality (10% vs 4.4%; p<0.001), as well as re-hospitalisation (23% vs 19%; p=0.001). After adjusting for potential confounders, PAD remained an independent predictor of 30-day MACE (odds ratio [OR], 1.6 [95% confidence interval (CI), 1.24–2.06]).
      Patients with compared to those without PAD had 2.5 times higher 1-year mortality rate (22% vs 9%; p<0.001). Co-existence of PAD remained an independent predictor of 1-year mortality after adjustment for potential confounders by multivariable regression analysis (OR, 1.62; 95% CI, 1.4–1.9). PAD was associated with a significant higher 1-year mortality rate across numerous sub-groups of patients including type of myocardial infarction (ST-elevation myocardial infarction vs non-ST-elevation myocardial infarction), and whether the patient underwent revascularisation.

      Conclusions

      Acute coronary syndrome with concomitant PAD represents a high-risk subgroup that warrants special attention and a more tailored approach.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Crawford F.
        • Welch K.
        • Andras A.
        • Chappell F.M.
        Ankle brachial index for the diagnosis of lower limb peripheral arterial disease.
        Cochrane Database Syst Rev. 2016; 9: CD010680
        • Mahoney E.M.
        • Wang K.
        • Keo H.H.
        • Duval S.
        • Smolderen K.G.
        • Cohen D.J.
        • et al.
        Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States.
        Circ Cardiovasc Qual Outcomes. 2010; 3: 642-651
        • Aronow W.S.
        • Ahn C.
        Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age.
        Am J Cardiol. 1994; 74: 64-65
        • Criqui M.H.
        • Langer R.D.
        • Fronek A.
        • Feigelson H.S.
        • Klauber M.R.
        • McCann T.J.
        • et al.
        Mortality over a period of 10 years in patients with peripheral arterial disease.
        N Engl J Med. 1992; 326: 381-386
        • Wilson P.W.F.
        • D'Agostino R.
        • Bhatt D.L.
        • Eagle K.
        • Pencina M.J.
        • Smith S.C.
        • et al.
        An international model to predict recurrent cardiovascular disease.
        Am J Med. 2019; 125: 695-703
        • Hussein A.A.
        • Uno K.
        • Wolski K.
        • Kapadia S.
        • Schoenhagen P.
        • Tuzcu E.M.
        • et al.
        Peripheral arterial disease and progression of coronary atherosclerosis.
        J Am Coll Cardiol. 2011; 57: 1220-1225
        • Rein P.
        • Saely C.H.
        • Silbernagel G.
        • Vonbank A.
        • Mathies R.
        • Drexel H.
        • et al.
        Systemic inflammation is higher in peripheral artery disease than in stable coronary artery disease.
        Atherosclerosis. 2015; 239: 299-303
        • Brevetti G.
        • Giugliano G.
        • Brevetti L.
        • Hiatt W.R.
        Inflammation in peripheral artery disease.
        Circulation. 2010; 122: 1862-1875
        • Burek K.A.
        • Sutton-Tyrrell K.
        • Brooks M.M.
        • Naydeck B.
        • Keller N.
        • Sellers M.A.
        • et al.
        Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the bypass angioplasty revascularization investigation (BARI).
        J Am Coll Cardiol. 1999; 34: 716-721
        • Grenon S.M.
        • Vittinghoff E.
        • Owens C.D.
        • Conte M.S.
        • Whooley M.
        • Cohen B.E.
        Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study.
        Vasc Med. 2013; 18: 176-184
        • Lee J.Y.
        • Lee S.W.
        • Lee W.S.
        • Han S.
        • Park Y.K.
        • Kwon C.H.
        • et al.
        Prevalence and clinical implications of newly revealed, asymptomatic abnormal ankle-brachial index in patients with significant coronary artery disease.
        JACC Cardiovasc Interv. 2013; 6: 1303-1313
        • Mukherjee D.
        • Eagle K.A.
        • Smith D.E.
        • Kline-Rogers E.M.
        • Chetcuti S.
        • Grossman P.M.
        • et al.
        Impact of extracardiac vascular disease on acute prognosis in patients who undergo percutaneous coronary interventions (data from the Blue Cross & Blue Shield of Michigan Cardiovascular Consortium [BMC2]).
        Am J Cardiol. 2003; 92: 972-974
        • Saw J.
        • Bhatt D.L.
        • Moliterno D.J.
        • Brener S.J.
        • Steinhubl S.R.
        • Lincoff A.M.
        • et al.
        The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials.
        J Am Coll Cardiol. 2006; 48: 1567-1572
        • Makowsky M.J.
        • McAlister F.A.
        • Galbraith P.D.
        • Southern D.A.
        • Ghali W.A.
        • Knudtson M.L.
        • et al.
        Lower extremity peripheral arterial disease in individuals with coronary artery disease: Prognostic importance, care gaps, and impact of therapy.
        Am Heart J. 2008; 155: 348-355
        • Morillas P.
        • Quiles J.
        • Cordero A.
        • Guindo J.
        • Soria F.
        • Mazón P.
        • et al.
        Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome.
        Am J Cardiol. 2009; 104: 1494-1498
        • Cordeiro F.
        • Mateus P.S.
        • Ferreira A.
        • Leao S.
        • Moz M.
        • Moreira J.I.
        • et al.
        Short-term prognostic effect of prior cerebrovascular and peripheral artery disease in patients with acute coronary syndrome: can we do better?.
        Eur Heart J Acute Cardiovasc Care. 2018; 7: 652-660
        • Bhatt D.L.
        • Peterson E.D.
        • Harrington R.A.
        • Ou F.-S.
        • Cannon C.P.
        • Gibson C.M.
        • et al.
        Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes.
        Eur Heart J. 2009; 30: 1195-1202
        • Guerrero M.
        • Harjai K.
        • Stone G.W.
        • Brodie B.
        • Cox D.
        • Boura J.
        • et al.
        Usefulness of the presence of peripheral vascular disease in predicting mortality in acute myocardial infarction patients treated with primary angioplasty (from the Primary Angioplasty in Myocardial Infarction Database).
        Am J Cardiol. 2005; 96: 649-654
        • Cotter G.
        • Cannon C.P.
        • McCabe C.H.
        • Michowitz Y.
        • Kaluski E.
        • Charlesworth A.
        • et al.
        Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis in Myocardial Infarction (OPUS-TIMI) 16 study.
        Am Heart J. 2003; 145: 622-627
        • Steg P.G.
        • Bhatt D.L.
        • Wilson P.W.
        • D’Agostino R.
        • Ohman E.M.
        • Röther J.
        • et al.
        One-year cardiovascular event rates in outpatients with atherothrombosis.
        JAMA. 2007; 297: 1197-1206
        • van Werkum J.W.
        • Heestermans A.A.
        • Zomer A.C.
        • Kelder J.C.
        • Suttorp M.-J.
        • Rensing B.J.
        • et al.
        Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.
        J Am Coll Cardiol. 2009; 53: 1399-1409
        • Bonaca M.P.
        • Nault P.
        • Giugliano R.P.
        • Keech A.C.
        • Pineda A.L.
        • Kanevsky E.
        • et al.
        Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: Insights from the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
        Circulation. 2018; 137: 338-350
        • Bonaca M.P.
        • Bhatt D.L.
        • Storey R.F.
        • Steg P.G.
        • Cohen M.
        • Kuder J.
        • et al.
        Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease.
        J Am Coll Cardiol. 2016; 67: 2719-2728
        • Chang S.T.
        • Chen C.L.
        • Chu C.M.
        • Chung C.M.
        • Hsu J.T.
        • Cheng H.W.
        • et al.
        Ankle-arm index as a predictor of lesion morphology and risk classification for coronary artery disease undergoing angioplasty.
        Int J Cardiol. 2006; 113: 385-390
        • Otah K.E.
        • Madan A.
        • Otah E.
        • Badero O.
        • Clark L.T.
        • Salifu M.O.
        Usefulness of an abnormal ankle-brachial index to predict presence of coronary artery disease in African-Americans.
        Am J Cardiol. 2004; 93: 481-483
        • Spencer F.A.
        • Lessard D.
        • Doubeni C.
        • Yarzebski J.
        • Gore J.M.
        • Goldberg R.J.
        Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting.
        Am Heart J. 2007; 153: 140-146
        • Brevetti G.
        • Piscione F.
        • Cirillo P.
        • Galasso G.
        • Schiano V.
        • Barbato E.
        • et al.
        In concomitant coronary and peripheral arterial disease, inflammation of the affected limbs predicts coronary artery endothelial dysfunction.
        Atherosclerosis. 2008; 201: 440-446
        • Nicholls S.J.
        • Hazen S.L.
        Myeloperoxidase and cardiovascular disease.
        Arterioscler Thromb Vasc Biol. 2005; 25: 1102-1111
        • Cassar K.
        • Bachoo P.
        • Ford I.
        • Greaves M.
        • Brittenden J.
        Platelet activation is increased in peripheral arterial disease.
        J Vasc Surg. 2003; 38: 99-103
        • Gremmel T.
        • Xhelili E.
        • Steiner S.
        • Koppensteiner R.
        • Kopp C.W.
        • Panzer S.
        Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty.
        Atherosclerosis. 2014; 232: 119-124
        • Eikelboom J.W.
        • Connolly S.J.
        • Bosch J.
        • Dagenais G.R.
        • Hart R.G.
        • Shestakovska O.
        • et al.
        Rivaroxaban with or without aspirin in stable cardiovascular disease.
        N Engl J Med. 2017; 377: 1319-1330